Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency
Cell Stem Cell · 2025
DOI: 10.1016/j.stem.2024.11.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Stem Cell, 2025. Verfasst von Jinkyu Park und 31 weiteren Autor:innen. Beteiligte Einrichtung: Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine, New Haven, CT 06511…. Hauptthemen laut MEDLINE: Tissue Engineering, Induced Pluripotent Stem Cells, Rats, Nude. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, U.S. Department of Defense.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine, New Haven, CT 06511, USA; Yale Stem Cell Center, New Haven, CT 06520, USA; Department of…
- Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine, New Haven, CT 06511, USA; Yale Stem Cell Center, New Haven, CT 06520, USA.
- Department of Surgery, Yale University, New Haven, CT 06520, USA.
- Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Anesthesiology, Yale University, New Haven, CT 06519, USA.
- Indiana Center for Regenerative Medicine and Engineering, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine, New Haven, CT 06511, USA; Department of Laboratory Medicine, Yale University, New Haven,…
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- U.S. Department of Defense
- National Institutes of Health
- National Research Foundation
Zitieren
APA
Park, J., Riaz, M., Qin, L., Zhang, W., Batty, L., Fooladi, S., Kural, M. H., Li, X., Luo, H., Xu, Z., Wang, J., Banno, K., Gu, S. X., Yuan, Y., Anderson, C. W., Ellis, M. W., Zhou, J., Luo, J., Shi, X., …, & Qyang, Y. (2025). Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency. Cell Stem Cell. https://doi.org/10.1016/j.stem.2024.11.006
Vancouver
Park J, Riaz M, Qin L, Zhang W, Batty L, Fooladi S, et al. Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency. Cell Stem Cell. 2025. doi:10.1016/j.stem.2024.11.006
BibTeX
@article{Park2025,
author = {Park, Jinkyu and Riaz, Muhammad and Qin, Lingfeng and Zhang, Wei and Batty, Luke and Fooladi, Saba and Kural, Mehmet H and Li, Xin and Luo, Hangqi and Xu, Zhen and Wang, Juan and Banno, Kimihiko and Gu, Sean X and Yuan, Yifan and Anderson, Christopher W and Ellis, Matthew W and Zhou, Jiahui and Luo, Jiesi and Shi, Xiangyu and Shin, Jae Hun and Liu, Yufeng and Lee, Seoyeon and Yoder, Mervin C and Elder, Robert W and Mak, Michael and Thorn, Stephanie and Sinusas, Albert and Gruber, Peter J and Hwa, John and Tellides, George and Niklason, Laura E and Qyang, Yibing},
title = {Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency},
journal = {Cell Stem Cell},
year = {2025},
doi = {10.1016/j.stem.2024.11.006}
}
EUVIMED